Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy

Androgen-deprivation therapy (ADT) induces prostate cancer immunogenic modulation (IM) by reducing human tumor cell expression of anti-apoptotic genes thus facilitating increased sensitivity to immune-mediated lysis. Through its stimulation of IM, ADT has been shown to synergize with active immunoth...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Kwilas, Anna R, Gameiro, Sofia R, Kim, Peter S, Malamas, Anthony S, Hodge, James W
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2015
Témata:
Author's View
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485836/
https://ncbi.nlm.nih.gov/pubmed/26155431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1009303
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky